Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Baricitinib Oral Tablet [Olumiant]
DRUG
2 trials
Sponsors
ASST Fatebenefratelli Sacco
, Assistance Publique - Hôpitaux de Paris
Conditions
Covid19
Rheumatoid Arthritis
Phase 3
Factorial Randomized Trial of Rendesivir and Baricitinib Plus Dexamethasone for COVID-19 (the AMMURAVID Trial)
NCT04832880
ASST Fatebenefratelli Sacco
Covid19
Start: 2021-04-06
End: 2022-12-31
Target: 4000
Updated: 2021-04-06
Phase 4
BARIcitinib Cognitive Emotional and Neural signaTuRE
Terminated
NCT05238896
Assistance Publique - Hôpitaux de Paris
Rheumatoid Arthritis
Start: 2022-06-27
End: 2023-03-31
Updated: 2023-11-18